Signature of both endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction
Baseline characteristics and 6-month echocardiographic assessment of chamber size in the REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure Trial: the first HFpEF device trial.